会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • ARYL-ISOXAZOL-4-YL-IMIDAZO[1, 5-A]PYRIDINE DERIVATIVES
    • ARYL-ISOXAZOL-4-YL-IMIDAZO [1,5-A]吡啶衍生物
    • WO2007074089A1
    • 2007-07-05
    • PCT/EP2006/069792
    • 2006-12-18
    • F. HOFFMANN-LA ROCHE AGBUETTELMANN, BerndDONG, JiaqiangHAN, BoKNUST, HennerTHOMAS, Andrew
    • BUETTELMANN, BerndDONG, JiaqiangHAN, BoKNUST, HennerTHOMAS, Andrew
    • C07D471/04A61K31/4188A61K31/437A61P25/28
    • C07D471/04
    • The present invention is concerned with aryl-isoxazol-4-yl-imidazo[1,5-a]pyridine derivatives of formula (I) wherein: R 1 is hydrogen, halogen, hydroxy, lower alkyl, benzyloxy or -O-(CH 2 )-(CO)-5 or 6 membered heteroaryl optionally substituted by aryl and lower alkyl; R 2 is hydrogen, lower alkyl, or -(CO)-R a ; R 3 is hydrogen, halogen, cyano, lower alkyl, or -(CO)-R a ; R a is hydroxy, lower alkoxy, NR'R'', wherein R' and R'' are each independently hydrogen, cycloalkyl, 5 or 6-membered heterocycloalkyl or lower alkyl optionally substituted by cycloalkyl, cyano, 5 or 6-membered heterocycloalkyl or 5 or 6-membered heteroaryl; as well as pharmaceutically acceptable acid addition salts thereof. It has been found that this class of compounds show high affinity and selectivity for GABA A α5 receptor binding sites and might be useful as cognitive enhancer or for the treatment of cognitive disorders like Alzheimer's disease.
    • 本发明涉及式(I)的芳基 - 异恶唑-4-基 - 咪唑并[1,5-a]吡啶衍生物,其中:R 1是氢,卤素,羟基,低级烷基, 任选被芳基和低级烷基取代的苄氧基或-O-(CH 2)2 - (CO)-5或6元杂芳基; R 2是氢,低级烷基或 - (CO)-R a; R 3是氢,卤素,氰基,低级烷基或 - (CO)-R a)。 R“是羟基,低级烷氧基,NR'R”,其中R'和R“各自独立地为氢,环烷基,5或6元杂环烷基或任选被环烷基取代的低级烷基,氰基 ,5或6元杂环烷基或5或6元杂芳基; 以及其药学上可接受的酸加成盐。 已经发现,这类化合物显示出对GABA A a5受体结合位点的高亲和力和选择性,并且可用作认知增强剂或用于治疗认知障碍如阿尔茨海默氏病。